IDEAS home Printed from https://ideas.repec.org/a/aph/ajpbhl/10.2105-ajph.2016.303199_8.html
   My bibliography  Save this article

Quantitative bias analysis in regulatory settings

Author

Listed:
  • Lash, T.L.
  • Fox, M.P.
  • Cooney, D.
  • Lu, Y.
  • Forshee, R.A.

Abstract

Nonrandomized studies are essential in the postmarket activities of the US Food and Drug Administration, which, however, must often act on the basis of imperfect data. Systematic errors can lead to inaccurate inferences, so it is critical to develop analytic methods that quantify uncertainty and bias and ensure that these methods are implemented when needed. "Quantitative bias analysis" is an overarching term for methods that estimate quantitatively the direction, magnitude, and uncertainty associated with systematic errors influencing measures of associations. The Food and Drug Administration sponsored a collaborative project to develop tools to better quantify the uncertainties associated with postmarket surveillance studies used in regulatory decision making. We have described the rationale, progress, and future directions of this project.

Suggested Citation

  • Lash, T.L. & Fox, M.P. & Cooney, D. & Lu, Y. & Forshee, R.A., 2016. "Quantitative bias analysis in regulatory settings," American Journal of Public Health, American Public Health Association, vol. 106(7), pages 1227-1230.
  • Handle: RePEc:aph:ajpbhl:10.2105/ajph.2016.303199_8
    DOI: 10.2105/AJPH.2016.303199
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2105/AJPH.2016.303199
    Download Restriction: no

    File URL: https://libkey.io/10.2105/AJPH.2016.303199?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Brian H. MacGillivray, 2019. "Null Hypothesis Testing ≠ Scientific Inference: A Critique of the Shaky Premise at the Heart of the Science and Values Debate, and a Defense of Value‐Neutral Risk Assessment," Risk Analysis, John Wiley & Sons, vol. 39(7), pages 1520-1532, July.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:10.2105/ajph.2016.303199_8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.